Terrestrial Bio, Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Semaglutide Delivered Epi-Intradermally by Microarray Patch (VX-201) Versus Subcutaneous Administration in Healthy Overweight and Obese Participants (NCT07673900) | Terrestrial Bio, Inc. | 2026-06-15 |
| Phase 1 Evaluation of H1 Influenza Vaccine Delivered by MIMIX MAP (NCT06125717) | Terrestrial Bio, Inc. | 2022-07-02 |
Track Terrestrial Bio, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.